Cardinal Health is trading higher today, primarily driven by the announcement early this morning that the company has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June
30, 2032. This positive development in the company's core distribution business is occurring alongside a broader upward trend in the medical distribution industry, as peers McKesson and Cencora are also posting notable gains. While investors continue to digest recent bullish sentiment regarding the company's growth str